Topics

Glioblastoma | Treatment | Clinical trials | Boron Neutron Capture Therapy

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Boron Neutron Capture Therapy

Kawabata S, Goto H, Narita Y, Furuse M, Nonoguchi N, Shidoh-Kazuki R, Eza K, Hirose K, Ohno M, Kondo N, Suzuki M, Tanaka H, Ono K, Nihei K, Wanibuchi M, Miyatake SI.
Extended follow-up of recurrent glioblastoma patients treated with boron neutron capture therapy (BNCT): Long-term survival from a Phase II trial (JG002) using Cyclotron Neutron Source and Boronophenylalanine.
Appl Radiat Isot. 2025 Aug 22;226:112118. doi: 10.1016/j.apradiso.2025.112118. PMID: 40865370. Interventional study˰ ˍ

Nakai K, Kumada H, Matsumoto Y, Baba K, Murakami M, Ishida T, Saito T, Nakamura M, Numajiri H, Mizumoto M, Sugii N, Miki S, Ishikawa E, Maruo K, Takemura M, Hashimoto K, Takahashi T, Hayashi T, Sakurai H.
Boron neutron capture therapy (BNCT) phase I clinical trial for newly diagnosed glioblastoma by newly developed accelerator at University of Tsukuba.
Appl Radiat Isot. 2025 Sep 3;226:112152. doi: 10.1016/j.apradiso.2025.112152. PMID: 40945116.Interventional study protocol. ˍ